PZ Cormay

PZ Cormay Non-Current Assets

The Non-Current Assets of PZ Cormay (CRM.WA) as of Nov 5, 2026 is -25.47 M PLN. In the previous year, Non-Current Assets was -21.88 M PLN — a change of 16.38% (lower).

Non-Current Assets

-25.47 MPLN

YoY

16.38%

Last updated:

Non-Current Assets of PZ Cormay is 2025 -25.47 M PLN. Non-Current Assets of PZ Cormay was 2024 -21.88 M PLN. It decreases by 16.38% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PZ Cormay Stock analysis

What does PZ Cormay do? PZ Cormay SA manufactures diagnostic reagents and laboratory equipment, offering products like biochemical rapid tests, vacuette tubes, and devices including ACCENT-300, ACCENT-200, PRESTIGE 24i, LIVIA analyzers, MYTHIC 18 hematology analyzers, and IChem 100 urinalysis apparatus. The company serves clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation, and specific protein recognition segments. Its products are distributed through Orphee SA, which acquired 100% stake in TT Management Sp z o o on September 1, 2014, to transfer Cormay group's production and distribution activities. Orphee SA, now holding full control of Cormay's operations, manages the distribution of PZ Cormay SA's diagnostic reagents and laboratory equipment. The firm's revenue comes from selling biochemical analyzers, hematology analyzers, and related products to healthcare facilities and laboratories. PZ Cormay SA's product portfolio includes drugs, biochemical rapid tests, and devices such as vacuette tubes, targeting clinical and diagnostic markets with a focus on specialized equipment for medical analysis. The company's revenue streams are derived from the sale of its analytical devices and reagents, with Orphee SA handling the distribution after the 2014 restructuring. PZ Cormay SA's products are used in clinical chemistry, hematology, and other diagnostic segments, with specific equipment like the ACCENT-300 and MYTHIC 18 being key offerings. The restructuring plan transferred production and distribution to Orphee SA, enabling streamlined operations and market access. PZ Cormay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PZ Cormay stock

Non-Current Assets of PZ Cormay is -25.47 M PLN in 2025.

Non-Current Assets of PZ Cormay changed from -21.88 M PLN to -25.47 M PLN, representing a 16.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets PZ Cormay since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's PZ Cormay historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PZ Cormay

All Key Metrics — PZ Cormay